Literature DB >> 18836656

The microRNA-200 family regulates epithelial to mesenchymal transition.

Emily L Paterson1, Natasha Kolesnikoff, Philip A Gregory, Andrew G Bert, Yeesim Khew-Goodall, Gregory J Goodall.   

Abstract

Epithelial-mesenchymal transition (EMT) is implicated in metastasis initiation and has recently been shown to be regulated by the miRNA-200 family and miR-205. Expression of these miRNAs was lost in invasive breast cancer cell lines displaying mesenchymal-like morphology suggesting these microRNAs may play a role in cancer metastasis.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18836656      PMCID: PMC5848679          DOI: 10.1100/tsw.2008.115

Source DB:  PubMed          Journal:  ScientificWorldJournal        ISSN: 1537-744X


  36 in total

1.  Inducible deletion of epidermal Dicer and Drosha reveals multiple functions for miRNAs in postnatal skin.

Authors:  Monica Teta; Yeon Sook Choi; Tishina Okegbe; Gabrielle Wong; Oliver H Tam; Mark M W Chong; John T Seykora; Andras Nagy; Dan R Littman; Thomas Andl; Sarah E Millar
Journal:  Development       Date:  2012-04       Impact factor: 6.868

Review 2.  MicroRNAs as mediators and therapeutic targets in chronic kidney disease.

Authors:  Johan M Lorenzen; Hermann Haller; Thomas Thum
Journal:  Nat Rev Nephrol       Date:  2011-03-22       Impact factor: 28.314

Review 3.  Metastamirs: a stepping stone towards improved cancer management.

Authors:  Nicole M A White; Eman Fatoohi; Maged Metias; Klaus Jung; Carsten Stephan; George M Yousef
Journal:  Nat Rev Clin Oncol       Date:  2010-11-02       Impact factor: 66.675

4.  Complete reversal of epithelial to mesenchymal transition requires inhibition of both ZEB expression and the Rho pathway.

Authors:  Shreyas Das; Bryan N Becker; F Michael Hoffmann; Janet E Mertz
Journal:  BMC Cell Biol       Date:  2009-12-21       Impact factor: 4.241

Review 5.  Rho kinase inhibition in diabetic kidney disease.

Authors:  Radko Komers
Journal:  Br J Clin Pharmacol       Date:  2013-10       Impact factor: 4.335

6.  Gemcitabine sensitivity can be induced in pancreatic cancer cells through modulation of miR-200 and miR-21 expression by curcumin or its analogue CDF.

Authors:  Shadan Ali; Aamir Ahmad; Sanjeev Banerjee; Subhash Padhye; Kristin Dominiak; Jacqueline M Schaffert; Zhiwei Wang; Philip A Philip; Fazlul H Sarkar
Journal:  Cancer Res       Date:  2010-04-13       Impact factor: 12.701

Review 7.  MicroRNAs (miRNAs) in cancer invasion and metastasis: therapeutic approaches based on metastasis-related miRNAs.

Authors:  Achim Aigner
Journal:  J Mol Med (Berl)       Date:  2011-01-14       Impact factor: 4.599

Review 8.  Roles and mechanisms of microRNAs in pancreatic cancer.

Authors:  Lidong Zhang; Md Saha Jamaluddin; Sarah M Weakley; Qizhi Yao; Changyi Chen
Journal:  World J Surg       Date:  2011-08       Impact factor: 3.352

Review 9.  MiRNAs-mediated cisplatin resistance in breast cancer.

Authors:  Xiu Chen; Peng Lu; Ying Wu; Dan-Dan Wang; Siying Zhou; Su-Jin Yang; Hong-Yu Shen; Xiao-Hui Zhang; Jian-Hua Zhao; Jin-Hai Tang
Journal:  Tumour Biol       Date:  2016-07-22

10.  miR-200c modulates ovarian cancer cell metastasis potential by targeting zinc finger E-box-binding homeobox 2 (ZEB2) expression.

Authors:  Yan-ming Lu; Chao Shang; Yang-ling Ou; Duo Yin; Yi-ning Li; Xiang Li; Ning Wang; Shu-lan Zhang
Journal:  Med Oncol       Date:  2014-07-23       Impact factor: 3.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.